[Recent advances in the epidemiology, clinical aspects and therapy of toxoplasmosis].
D000026:Abortion, Habitual / Q000209:etiology; D004357:Drug Synergism; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007933:Leucomycins / Q000627:therapeutic use; D008206:Lymphatic Diseases; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000517:prevention & control; D011739:Pyrimethamine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000254:growth & development; D014123:Toxoplasmosis / Q000145:classification / Q000150:complications / Q000276:immunology / Q000473:pathology; D014125:Toxoplasmosis, Congenital / Q000276:immunology
D007933:Leucomycins; D013449:Sulfonamides; D011739:Pyrimethamine
Recenti progressi sulla epidemiologia, clinica e terapia della toxoplasmosi.